Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients

Alan Menter; Kelly M Cordoro; Dawn M R Davis; Daniela Kroshinsky; Amy S Paller; April W Armstrong; Cody Connor; Boni E Elewski; Joel M Gelfand; Kenneth B Gordon; Alice B Gottlieb; Daniel H Kaplan; Arthur Kavanaugh; Matthew Kiselica; Dario Kivelevitch; Neil J Korman; Mark Lebwohl; Craig L Leonardi; Jason Lichten; Henry W Lim; Nehal N Mehta; Sylvia L Parra; Arun L Pathy; Elizabeth A Farley Prater; Reena N Rupani; Michael Siegel; Benjamin Stoff; Bruce E Strober; Emily B Wong; Jashin J Wu; Vidhya Hariharan; Craig A Elmets

doi:10.1016/j.jaad.2019.08.049

Joint American Academy of Dermatology-National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis in pediatric patients

J Am Acad Dermatol. 2020 Jan;82(1):161-201. doi: 10.1016/j.jaad.2019.08.049. Epub 2019 Nov 5.

Authors

Alan Menter¹, Kelly M Cordoro², Dawn M R Davis³, Daniela Kroshinsky⁴, Amy S Paller⁵, April W Armstrong⁶, Cody Connor⁷, Boni E Elewski⁷, Joel M Gelfand⁸, Kenneth B Gordon⁹, Alice B Gottlieb¹⁰, Daniel H Kaplan¹¹, Arthur Kavanaugh¹², Matthew Kiselica¹³, Dario Kivelevitch¹, Neil J Korman¹⁴, Mark Lebwohl¹⁵, Craig L Leonardi¹⁶, Jason Lichten¹³, Henry W Lim¹⁷, Nehal N Mehta¹⁸, Sylvia L Parra¹⁹, Arun L Pathy²⁰, Elizabeth A Farley Prater²¹, Reena N Rupani¹⁵, Michael Siegel²², Benjamin Stoff²³, Bruce E Strober²⁴, Emily B Wong²⁵, Jashin J Wu²⁶, Vidhya Hariharan²⁷, Craig A Elmets⁷

Affiliations

¹ Baylor University Medical Center, Dallas, Texas.
² University of California, San Francisco School of Medicine, Department of Dermatology, San Francisco, California.
³ Mayo Clinic, Rochester, Minnesota.
⁴ Massachusetts General Hospital, Boston, Massachusetts.
⁵ Northwestern University Feinberg School of Medicine, Chicago, Illinois.
⁶ University of Southern California, Los Angeles, California.
⁷ University of Alabama, Birmingham, Alabama.
⁸ University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
⁹ Medical College of Wisconsin, Milwaukee, Wisconsin.
¹⁰ Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, New York.
¹¹ University of Pittsburgh, Pittsburgh, Pennsylvania.
¹² University of San Diego, San Diego, California.
¹³ National Psoriasis Foundation.
¹⁴ University Hospitals Cleveland Medical Center, Cleveland, Ohio.
¹⁵ Icahn School of Medicine at Mount Sinai, New York, New York.
¹⁶ Central Dermatology, St Louis, Missouri.
¹⁷ Department of Dermatology, Henry Ford Medical Center, Detroit, Michigan.
¹⁸ National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
¹⁹ Dermatology and Skin Surgery, Sumter, South Carolina.
²⁰ Colorado Permanente Medical Group, Centennial, Colorado.
²¹ University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma.
²² Pediatric Dermatology Research Alliance, Indianapolis, Indiana.
²³ Emory University School of Medicine, Atlanta, Georgia.
²⁴ Central Connecticut Dermatology, Cromwell, Connecticut; Yale University, New Haven, Connecticut.
²⁵ San Antonio Uniformed Services Health Education Consortium, Joint-Base San Antonio, Texas.
²⁶ Dermatology Research and Education Foundation, Irvine, California.
²⁷ American Academy of Dermatology, Rosemont, Illinois. Electronic address: vhariharan@aad.org.

PMID: 31703821
DOI: 10.1016/j.jaad.2019.08.049

Abstract

Psoriasis is a chronic, multisystem, inflammatory disease that affects approximately 1% of children, with onset most common during adolescence. This guideline addresses important clinical questions that arise in psoriasis management and provides evidence-based recommendations. Attention will be given to pediatric patients with psoriasis, recognizing the unique physiology, pharmacokinetics, and patient-parent-provider interactions of patients younger than 18 years old. The topics reviewed here mirror those discussed in the adult guideline sections, excluding those topics that are irrelevant to, or lack sufficient information for, pediatric patients.

Keywords: clinical guidelines for psoriasis; comorbidities; dermatology; guidelines; pediatric; pediatric psoriasis; psoriasis; psoriasis guidelines; skin disease.

Publication types

Duplicate Publication
Practice Guideline

MeSH terms

Adolescent
Adrenal Cortex Hormones / therapeutic use
Anthralin / therapeutic use
Biological Products / therapeutic use*
Calcineurin Inhibitors / therapeutic use
Cardiovascular Diseases / epidemiology
Child
Child, Preschool
Coal Tar / therapeutic use
Comorbidity
Cyclosporine / therapeutic use
Dermatologic Agents / therapeutic use*
Dyslipidemias / epidemiology
Evidence-Based Medicine
Humans
Infant
Infant, Newborn
Inflammatory Bowel Diseases / epidemiology
Insulin Resistance
Mental Health
Metabolic Syndrome / epidemiology
Methotrexate / therapeutic use*
Nicotinic Acids / therapeutic use
Obesity / epidemiology
Photochemotherapy*
Psoriasis / drug therapy*
Psoriasis / epidemiology*
Psoriasis / psychology
Retinoids / therapeutic use

Substances

Adrenal Cortex Hormones
Biological Products
Calcineurin Inhibitors
Dermatologic Agents
Nicotinic Acids
Retinoids
Coal Tar
tazarotene
Cyclosporine
Anthralin
Methotrexate